Nonalcoholic fatty liver disease predicts MACE in STEMI
(HealthDay)—For patients without diabetes with ST-segment myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), nonalcoholic fatty liver disease (FLD) independently predicts impaired ...
Nov 30, 2015
0
0